Industry NewsCellular Dynamics Announces Launch of World’s Largest Public Stem Cell Bank and the Availability of the First 300 iPSC Lines
Industry NewsCellular Dynamics to Host iForum™ Meetings Focused on Human iPSC Research and Applications
Product NewsCord Blood Registry and Cellular Dynamics International Announce Collaboration to Reprogram Newborn Stem Cells into Induced Pluripotent Stem Cells
Industry NewsCellular Dynamics and Northwestern University Take First Steps Toward Rebuilding an Organ Using Manufactured Human Cells
Product NewsCellular Dynamics Awarded $1.2 Million NEI Contract for Developing Patient-derived Stem Cells in Gear-up for Age-related Macular Degeneration Trial
Product NewsCellular Dynamics Awarded Patents Covering Derivation of Pluripotent Stem Cells from Fresh or Banked Human Blood Samples
Product NewsCellular Dynamics Announces Launch of iCell® DopaNeurons, Neural Floor Plate-Derived Midbrain Dopaminergic Neurons
Industry NewsCellular Dynamics Signs Agreement with Nestlé Institute of Health Sciences to Supply iCell® and MyCell® Products for Nutritional Research
Industry NewsJain Foundation Signs Agreement with Cellular Dynamics to Create iPSC Lines from Patients with Muscular Dystrophies
Product NewsThe Hamner Institutes and Cellular Dynamics Collaborate to Develop In Vitro Assays Using Human iPS Cell-derived Hepatocytes
Product NewsCellular Dynamics Receives Formal Notice of Grant Award (NGA) for $16 Million Stem Cell Banking Project
Product NewsCellular Dynamics Issued U.S. Patent Covering Differentiation of iPS Cells into Endothelial, Hematopoietic Cells
Product NewsCellular Dynamics International Expands MyCell Products Line with Disease Models, Genetic Engineering Patents
Product NewsCellular Dynamics International Opens Facility in California, Leasing Space from the Buck Institute to Derive and Bank Human Induced Pluripotent Stem Cells
Product NewsCellular Dynamics and Coriell Institute for Medical Research Awarded Multi-Million Dollar Grants from California Institute for Regenerative Medicine to Manufacture and Bank Stem Cell Lines
Product NewsCellular Dynamics Announces Presentations at the Society of Toxicology’s 52nd Annual Meeting Demonstrating the Expanding Utility of iCell® Products on Toxicology Assay Development
Product NewsCellular Dynamics Announces Agreement with AstraZeneca on Use of iPSC-derived Human Cells in Drug Discovery Research
Product NewsGE Healthcare and Cellular Dynamics International Agree to Sublicense for Cellular Assay Patents
